Erythropoietin: Recent Developments in the Treatment of Spinal Cord Injury
Erythropoietin (EPO), originally identified for its critical function in regulating production and survival of erythrocytes, is a member of the type 1 cytokine superfamily. Recent studies have shown that EPO has cytoprotective effects in a wide variety of cells and tissues. Here is presented the ana...
Saved in:
| Main Authors: | Stephana Carelli, Giovanni Marfia, Anna Maria Di Giulio, Giorgio Ghilardi, Alfredo Gorio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Neurology Research International |
| Online Access: | http://dx.doi.org/10.1155/2011/453179 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adipose-Derived Stem Cells from Fat Tissue of Breast Cancer Microenvironment Present Altered Adipogenic Differentiation Capabilities
by: Federica Rey, et al.
Published: (2019-01-01) -
Recombinant human erythropoietin plus methylprednisolone versus methylprednisolone in treatment of acute spinal cord injury:protocol for a systematic review and meta-analysis
by: Yu He, et al.
Published: (2022-12-01) -
Spinal cord stimulation for cardiovascular function following spinal cord injury
by: Soshi Samejima
Published: (2025-01-01) -
Evolution of Spinal Cord Swelling in Acute Traumatic Spinal Cord Injury
by: Hasan Asif, et al.
Published: (2025-01-01) -
Potential benefits of spinal cord stimulation treatment on quality of life for paralyzed patients with spinal cord injury
by: Xiang-Ling Huang, et al.
Published: (2023-01-01)